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STAT5a/PPARc Pathway Regulates Involucrin
Expression in Keratinocyte Differentiation
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Lujun Yang1, Xiaoling Wang1, Satoshi Hirakawa1, Mikiko Tohyama1, Toshimasa Yamauchi2,3, Kadowaki
Takashi2,3, Hiroyuki Kagechika4 and Koji Hashimoto1
Signal transducers and activators of transcription (STATs) are critical to growth factor-mediated intracellular
signal transduction. We observed the rapid expression and activation of STAT5a during keratinocyte
differentiation induced by suspension culture. STAT5a expression preceded that of involucrin, an important
molecule in the terminal differentiation of keratinocytes. To determine whether STAT5a regulated involucrin
expression, we expressed a dominant-negative (dn) STAT5a that blocks the dimerization of STAT5 and inhibits its
nuclear translocation. We found that dn-STAT5a inhibited involucrin expression in keratinocytes. Given that
STAT5 regulates adipogenesis via activating the peroxisome proliferator-activated receptor (PPAR) g signal, we
hypothesized that STAT5a regulated involucrin expression in the same manner. To test this hypothesis, we
examined the expression and transactivation of PPARg in a suspension culture of keratinocytes. Suspension
culture induced PPARg expression and triggered PPARg transactivation rapidly and dn-STAT5a downregulated
this induction and suppressed PPARg transactivation. Furthermore, preincubation with the PPARg/retinoid
X-receptor inhibitor HX-531 or the introduction of a dn-PPARg prevented the activation of involucrin promoter
and inhibited its induction. This report provides early evidence of a major role for STAT5a in the differentiation
of keratinocytes, where it contributes to involucrin expression by activating the PPARg signal.
Journal of Investigative Dermatology (2007) 127, 1728–1735; doi:10.1038/sj.jid.5700758; published online 1 March 2007
INTRODUCTION
Signal transducers and activators of transcription (STATs) are
a family of transcription factors that are essential for
intracellular signaling in response to stimulation by cyto-
kines, growth factors, and hormones (Horvath, 2000). STAT
proteins form homo- or heterodimers on tyrosine phosphor-
ylation and dimerized STAT proteins immediately enter the
nucleus, where they bind to specific DNA sequences in the
promoters of various genes and mediate transcriptional
regulation. In mammals, seven STAT proteins have been
identified, including two highly similar STAT5 isoforms.
Although STAT5a and STAT5b are roughly 95% similar at the
cDNA level, they exhibit both redundant and nonredundant
functions in vivo, probably because of differences in their
transactivation domains (Grimley et al., 1999). STAT5s are
involved in a variety of cellular processes, as has been
demonstrated in STAT5 knockout mice (Coffer et al., 2000;
Levy and Gilliland, 2000). Adipogenesis is a complex process
controlled by the interplay of signals emanating from both
environmental and intracellular factors. STAT5s are reported
to function in fat-cell development, adipocyte differentiation,
and lipid accumulation by regulating peroxisome prolifera-
tor-activated receptor (PPAR)g and CCAAT-enhancer binding
proteins a signals (Stephens et al., 1999; Nanbu-Wakao et al.,
2002; Floyd and Stephens, 2003; Stewart et al., 2004).
PPARs are transcription factors belonging to the ligand-
activated nuclear hormone receptor superfamily. Upon
binding exogenous or endogenous ligands, PPARs form
heterodimers with the retinoid X receptor (RXR), recruit a
coactivator, and facilitate the transcription of target genes
involved in many cellular functions, including differentiation
(Kuenzli and Saurat, 2003). All of the PPAR superfamily
members – PPARa, PPARb/d, and PPARg – have been
identified in keratinocytes and have been shown to play
physiological roles in epidermopoiesis, such as in keratino-
cyte proliferation and differentiation (Kuenzli and Saurat,
2003).
Although the function of STAT5 has been studied in
several cell types, its roles in skin and keratinocytes are
unclear, despite the observation of its in vivo and in vitro
expression in human keratinocytes (Poumay et al., 1999;
Nishio et al., 2001). We hypothesized that STAT5 is involved
in keratinocyte differentiation because it is expressed to a
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substantial degree in the granular layer and in the horny
keratinized cells of the epidermis (Nishio et al., 2001). We
present evidence that STAT5a is activated and essential for
involucrin expression in suspension cultures of keratinocytes.
We further demonstrate that STAT5a regulates PPARg
activation, which contributes to involucrin expression during
keratinocyte differentiation. This report demonstrates early
evidence of a vital role for STAT5a in involucrin expression.
RESULTS
Rapid induction of STAT5a but not STAT5b during keratinocyte
differentiation
We investigated the expression of STAT5s in a suspension
culture model of keratinocyte differentiation (Watt et al.,
1988). For the suspension cultures, we used polyhydrox-
yethylmethacrylate-coated culture plates, which inhibit cell-
to-extracellular matrix interactions but not cell-to-cell inter-
actions (Wakita and Takigawa, 1999). The expression of
mRNAs for both STAT5a and STAT5b was detected in the
suspension culture. STAT5a mRNA started to increase at
3 hours, reached a peak at 12 hours, and was induced more
than 20-fold; the STAT5b mRNA level did not change during
suspension culture (Figure 1a). Immunoblotting confirmed
the mRNA data: STAT5a protein increased within 6 hours and
peaked at 24 hours, whereas the level of STAT5b remained
unchanged (Figure 1b). We used a phospho-specific antibody
to examine STAT5 phosphorylation at conserved tyrosine,
which is required for the activation of STAT5 (Grimley et al.,
1999). As shown in Figure 1b, STAT5 was rapidly phos-
phorylated in cell suspension and the level of phosphorylated
STAT5 varied with the level of total STAT5a protein. Next, we
investigated the nuclear translocation of STAT5s. After
suspension culture, the cells were harvested at the indicated
times and the levels of STAT5a, phospho-STAT5, and STAT5b
in the nuclear fraction were determined using Western blots.
As shown in Figure 1c, STAT5a and phospho-STAT5 were
definitely detected in the nucleus beginning at 6 hours in
suspension culture, implying that suspension culture triggers
the nuclear translocation of phosphorylated STAT5a. In
contrast, STAT5b protein was only detected weakly in the
nuclear fraction and its level in suspension culture remained
constant. These data suggest that STAT5a is transactivated
during keratinocyte differentiation induced by suspension
culture.
Involucrin expression has been analyzed as an important
marker of keratinocyte differentiation (Eckert et al., 2004). In
suspension culture, involucrin was induced in a time-
dependent manner and occurred after the activation of
STAT5a (Figure 1a and b). These data suggested the
possibility of a causal relationship between STAT5a and
involucrin expression.
Regulation of involucrin expression by STAT5a during
keratinocyte differentiation
To explore the function of STAT5a in involucrin expression,
we constructed an adenovirus expression vector (Ax) carrying
a dominant-negative (dn) mutant of STAT5a (Axdn-STAT5a)
that inhibits the dimerization of phosphorylated STAT5a, a
key step required for nuclear translocation and DNA binding
(Ariyoshi et al., 2000), and infected keratinocytes at different
multiplicities of infection (m.o.i.). After 24 hours, sufficient
STAT5a protein expression was detected with an m.o.i. of 50
(Figure 2a). To investigate the role of STAT5a in the activation
of the involucrin promoter, we performed a luciferase assay.
Keratinocytes transfected with an involucrin promoter-luci-
ferase reporter plasmid (pINV-Luc) were infected with
adenovirus at an m.o.i. of 50 and then subjected to
suspension culture for 24 hours. The reporter activity
increased about sevenfold in suspension culture, which was
significantly suppressed by dn-STAT5a (Figure 2b). Subse-
quently, we also examined the influence of dn-STAT5a on
involucrin mRNA and protein expression. Infection with
Axdn-STAT5a suppressed the suspension culture-induced
expression of involucrin mRNA (Figure 2c) and protein
(Figure 2d) by more than 50%. These data unequivocally
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Figure 1. Suspension culture resulted in the induction and activation of
STAT5a. (a) Keratinocytes were plated onto polyhydroxyethylmethacrylate-
coated plates and cultures were incubated for the indicated times. Total RNA
was collected and real-time RT-PCR was performed to detect the mRNA
levels of STAT5a, STAT5b, and involucrin. The relative mRNA expression
levels were expressed as the mean7SD (n¼ 3). An asterisk indicates
significant deviation from the control (Po0.05). (b) Suspension cultures were
established and cells were collected after the indicated times of incubation.
Total protein samples were analyzed by Western blotting with antibodies
against involucrin, STAT5a, STAT5b, and phospho-STAT5. The data shown
are representative of three separate experiments. (c) Keratinocytes were
collected at the indicated times after suspension culture. The nuclear fraction
was subjected to antibodies against STAT5a, phospho-STAT5, and STAT5b.
The data shown are representative of three separate experiments.
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defined a positive role of STAT5a in the expression of
involucrin during keratinocyte differentiation.
Inducible expression and transactivation of PPARc during
keratinocyte differentiation
Human involucrin promoter activity is complex and cell
type-specific. The involucrin promoter contains binding
sites for transcription factors of the activator protein-1, Sp-1,
and CCAAT-enhancer binding protein families, but no STAT-
binding site has been detected (Eckert et al., 2004). Thus,
STAT5a must regulate involucrin expression in an indirect
manner.
We hypothesized that STAT5a acts on involucrin expres-
sion by controlling the PPARg signal, given that STAT5a/
PPARg functions in adipocyte differentiation (Nanbu-Wakao
et al., 2002; Floyd and Stephens, 2003). We first examined
the expression of PPARs in suspension cultures of keratino-
cytes. As shown in Figure 3a and b, PPARa and PPARb/d
remained relatively constant during culture, whereas the
expression of PPARg mRNA and protein was significantly
induced, with expression beginning to increase at 6 hours and
peaking at 24 hours after suspension culture. We also
performed electrophoretic mobility shift assays (EMSA) to
examine the DNA-binding activity of PPARg in nuclear
extracts of keratinocytes. This activity was also induced in
suspension culture, and a significant effect was seen between
12 and 36 hours post-suspension (Figure 3c). The PPARg
probe used for EMSA was specific, as the protein–DNA
complex was removed by the addition of unlabeled PPARg
probe (lane 2) and was not affected by the presence of the
unlabeled probe for PPARa or PPARb/d (Figure 3d). The
protein–DNA complex could also be supershifted by pre-
incubation of nuclear extracts with an antibody specific to
PPARg (lane 4), but not with antibodies to PPARa or b/d
(Figure 3e). Our data suggest that the PPARg signal was
activated in keratinocyte differentiation.
STAT5a regulates the expression and transactivation of PPARc
during keratinocyte differentiation
To investigate whether STAT5a regulates the induction of
PPARg in suspension culture, keratinocytes were infected
with Axdn–STAT5a before being subjected to suspension
culture and the PPARg mRNA and protein levels were
analyzed. In support of the hypothesis, dn-STAT5a inhibited
PPARg expression in suspension culture (Figure 4a and b),
confirming the previous report in adipocytes (Rosen et al.,
2000; Nanbu-Wakao et al., 2002; Floyd and Stephens,
2003). In addition, dn-STAT5a almost completely blocked
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Figure 2. dn-STAT5a-inhibited involucrin expression. (a) Subconfluent
keratinocytes were infected with Ax carrying dn-STAT5a at different m.o.i.
values. After 24 hours, cells were collected and the protein level of STAT5a
was detected by immunoblotting. (b) Keratinocytes were transfected with
involucrin reporter plasmid (pINV-Luc) and pRL-TK (Renilla luciferase) using
FuGENE6. After 24 hours, the cells were infected with Ax1W or Axdn–STAT5a
and cultured for an additional 24 hours. Then, the cells were subjected to
suspension culture for 24 hours. Luciferase activity was measured using the
Dual-Luciferase reporter assay system. Transfection was performed in
triplicate. The relative luciferase activity was calculated by normalizing to the
Renilla luciferase activity and is presented as the mean7SD (n¼3).
An asterisk indicates significant deviation (Po0.05). (c) Keratinocytes were
infected with Axdn–STAT5a or a control (Ax1W) for 24 hours and suspension
cultures were established. Total RNA was collected 24 or 36 hours post-
suspension and involucrin mRNA detected by real-time RT-PCR. The
involucrin mRNA expression is presented as the mean7SD (n¼3).
An asterisk indicates significant deviation (Po0.05). (d) Keratinocytes were
infected with Axdn–STAT5a or Ax1W for 24 hours before suspension culture.
Cells were collected 36 hours after suspension and the level of involucrin
protein was evaluated on Western blots. The data shown are representative of
three separate experiments.
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Figure 3. Suspension culture activated PPARc. (a) Total RNA was collected
as described in Figure 1a and the mRNA levels of PPAR family members were
evaluated by real-time RT-PCR. The relative mRNA expression levels are
expressed as the mean7SD (n¼ 3). An asterisk indicates significant deviation
from the control (Po0.05). (b) Keratinocytes were subjected to suspension
culture for the indicated times. PPARa, b/d, and g protein levels were detected
by immunoblotting. (c) Keratinocytes were subjected to suspension culture
and nuclear extracts were collected at the indicated times. Biotin-labeled
PPARg probe was incubated with nuclear protein and EMSA was performed.
(d) Nuclear extracts from keratinocytes of 24-hour suspension culture were
incubated with biotin-labeled PPARg. Lane 1: no addition of unlabeled probe;
lane 2: addition of unlabeled probe for PPARg; lane 3: addition of unlabeled
PPARa probe; lane 4: addition of unlabeled PPARb/d probe. (e) Nuclear
extracts from keratinocytes of 24-hour suspension culture were mixed with
biotin-labeled PPARg probe in the presence of antibodies. Note the
supershifted PPARg-DNA complex seen using an anti-PPARg antibody
(sb: supershifted band). Lane 1: no antibody added; lanes 2–6: addition of
normal goat IgG, normal rabbit IgG, goat anti-PPARg, rabbit anti-PPARa,
and rabbit anti-PPARb/d, respectively. The data shown are representative of
three separate experiments.
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the DNA-binding activity of PPARg triggered by suspension
culture (Figure 4c). These results indicate that STAT5a regu-
lates the PPARg signal during keratinocyte differentiation.
Regulation of involucrin expression by PPARc during
keratinocyte differentiation
The treatment of cultured human keratinocytes with ciglita-
zone, a PPARg activator, has been shown to increase
involucrin and transglutaminase 1 mRNA levels. Moreover,
topical treatment of hairless mice with ciglitazone increases
both involucrin and filaggrin expression (Mao-Qiang et al.,
2004). We found that stimulation with pioglitazone, another
PPARg activator, upregulated involucrin expression in human
keratinocytes (data not shown), suggesting that PPARg
activation stimulates the expression of differentiation mar-
kers. In this study, we investigated whether PPARg is
important for involucrin expression induced in suspension
culture by using HX-531, which has been shown to inhibit
significantly PPARg/RXR transactivation in adipocytes (Ya-
mauchi et al., 2001) and in other epithelial cells (Varley et al.,
2004). A luciferase assay was performed to investigate the
role of HX531 in activating the involucrin promoter.
Keratinocytes transfected with report plasmids were treated
with HX531 and then subjected to suspension culture for
24 hours. The suspension culture-increased luciferase activity
was inhibited by HX531 (Figure 5a). The expression of
involucrin mRNA and protein, which was significantly
induced by suspension culture, was also lowered by
pretreatment with HX531 (Figures 5b and c). Although it is
theoretically possible that HX-531 inhibits vitamin D
receptor/RXR activation as an antagonist of RXR, Yamauchi
et al. (2001) reported that HX-531 had no apparent effect on
the transactivation of RXR partners other than PPARg in
adipocytes. In our study, this possibility is unlikely because
vitamin D-receptor expression in keratinocytes is anchorage-
dependent and is significantly inhibited by suspension culture
(Segaert et al., 1998).
We infected keratinocytes with Axdn-PPARg, which
inhibits thiazolidinedione-induced target gene transcription
and cellular differentiation in human adipocytes (Gurnell
et al., 2000). In human keratinocytes, infection of Axdn–P-
PARg at an m.o.i. of 10 resulted in protein expression (Figure
6a) sufficient to inhibit the activation of the involucrin
promoter in suspension culture (Figure 6b) and to decrease
the involucrin mRNA and protein expression (Figure 6c and
d). These data indicate that PPARg is an important regulator
of involucrin transcription and that PPARg transactiva-
tion stimulates involucrin expression during keratinocyte
differentiation.
DISCUSSION
The three PPAR isotypes exhibit distinct patterns of tissue
distribution. In human epidermis, PPARb/d is the prevalent
PPAR subtype and PPARa and PPARg are expressed at lower
levels (Kuenzli and Saurat, 2003). In the suspension culture of
keratinocytes, the expression and transcriptional activity of
PPARg significantly increased, whereas PPARa expression
was unchanged and the PPARb/d level remained constantly
high. Our data are not completely consistent with the report
that in the ex vivo differentiation of keratinocytes, the level of
PPARb/d remained unchanged, whereas PPARa and PPARg
increased significantly (Rivier et al., 1998). In differentiating
keratinocytes stimulated by phorbol ester, PPARb/d mRNA
expression increased (Matsuura et al., 1999) and we have
also detected increased expression of PPARb/d and PPARg,
but not PPARa, in VD3-induced keratinocyte differentiation
(Dai et al., unpublished data). These conflicting data may be
attributable to the different differentiation models used. In this
study, we demonstrated the important role of PPARg in
involucrin expression by blocking PPARg/RXR transactiva-
tion. The PPARg ligand has been shown to induce involucrin
expression in keratinocytes directly or to act synergistically
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Figure 4. The induction of PPARc expression by suspension culture was
suppressed by dn-STAT5a. RNA samples were prepared as described in Figure
2b. Real-time RT-PCR was performed to detect the level of PPARg mRNA
(a) The relative mRNA expression level is expressed as the mean7SD (n¼ 3).
An asterisk indicates significant deviation (Po0.05). (b) Keratinocytes were
infected with Axdn–STAT5a or Ax1W. Cells were collected 24 hours after
suspension culture and the level of PPARg protein was detected on Western
blots. (c) Keratinocytes were infected with Axdn–STAT5a or Ax1W. Nuclear
extracts were collected 24 hour after cell suspension and the DNA-binding
activity of PPARg protein was detected by EMSA. The data shown are
representative of three separate experiments.
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with other factors (Westergaard et al., 2001; Mao-Qiang
et al., 2004). The regulation of differentiation-associated
genes by PPARg has also been reported in other normal
epithelia (Varley et al., 2004). The ligands of PPARg show an
ability to regulate cell differentiation and cutaneous home-
ostasis similar to that of other nuclear hormones, such as
glucocorticoids, retinoids, and vitamin D. Treatment with
PPARg-selective ligands has promoted differentiation and
normalized the histological features of psoriatic skin in organ
culture (Ellis et al., 2000) and in a murine model of epidermal
hyperplasia (Demerjian et al., 2006). Together with our study,
this suggests that PPARg probably contributes to keratinocyte
differentiation and normalizes epidermal histology by regu-
lating involucrin expression. Although PPARg functions in
involucrin transcription, the PPARg signal activates the
involucrin promoter in a complicated manner and the details
are still unclear; it might involve the transcriptional activation
of activator protein-1 and CCAAT-enhancer binding proteins
(Dai et al., unpublished data).
Our study demonstrated that STAT5a is induced, acti-
vated, and involved in involucrin induction, whereas STAT5b
expression remains weak and unchanged during suspension
culture. Such a difference between isoforms in cell differ-
entiation has been shown previously; STAT5a was sufficient
to induce adipogenesis in BALB/C and NIH-3T3 cells,
whereas STAT5b alone was not adipogenic. However, the
presence of STAT5b enhanced the adipogenic ability of
STAT5a (Floyd and Stephens, 2003).
The expression of STAT5 increases early during the course
of adipogenesis (Stephens et al., 1999); STAT5 becomes
activated during differentiation and it contributes to the
enhanced expression of PPARg (Nanbu-Wakao et al., 2002).
Epithelial cell differentiation in vitro is reminiscent of
adipocyte differentiation in some ways and the ability of
STAT5a to induce involucrin expression in suspension culture
might be mediated by its ability to regulate PPARg expression
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Figure 5. HX-531 suppresses the expression of involucrin. (a) The reporter
plasmids were introduced into the keratinocytes as described in Figure 2b.
After 24 hours, the cells were treated with 1 mM HX-531 or with DMSO for
2 hours and were then subjected to suspension culture for 24 hours. Luciferase
activity was measured using the Dual-Luciferase reporter assay system.
Transfection was performed in triplicate. The relative luciferase activity was
calculated by normalizing to the Renilla luciferase activity and is presented as
the mean7SD (n¼ 3). An asterisk indicates significant deviation (Po0.05).
(b) Keratinocytes were pretreated with 1 mM HX-531 or with DMSO for 2 hours
before being subjected to suspension culture. RNA was collected
post-suspension and involucrin mRNA was detected by real-time RT-PCR;
the relative mRNA expression level is expressed as the mean7SD (n¼ 3).
An asterisk indicates significant deviation (Po0.05). (c) Keratinocytes were
treated with HX-531 for 2 hours and then subjected to suspension cultures;
the cells were collected at 36 hours. The level of involucrin protein was
evaluated on Western blot. The data shown are representative of three
separate experiments.
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Figure 6. Infection with Axdn-PPARc inhibited involucrin expression.
(a) Subconfluent keratinocytes were infected with Axdn-PPARg at different
m.o.i. values. After 24 hours, cells were collected and PPARg protein was
detected by immunoblotting. (b) The reporter plasmids (pINV-Luc and
pRL-TK) were introduced into the keratinocytes as described in Figure 2b.
After 24 hours, the cells were incubated with Ax1W or Axdn–PPARg for an
additional 24 hours. Then, the cells were subjected to suspension culture and
the luciferase activity was measured as described in Figure 2b. Transfection
was performed in triplicate. The relative luciferase activity was calculated by
normalizing to the Renilla luciferase activity and is presented as the
mean7SD (n¼ 3). An asterisk indicates significant deviation (Po0.05).
(c) Keratinocytes were infected with Axdn–PPARg or Ax1W for 24 hours and
suspension cultures were established. Total RNA was collected 30 hours after
suspension culture and involucrin mRNA was detected by real-time RT-PCR.
The relative mRNA expression level is expressed as the mean7SD (n¼3).
An asterisk indicates significant deviation (Po0.05). (d) Keratinocytes were
infected with Axdn–PPARg or Ax1W for 24 hours before suspension culture.
Cells were collected 36 hours after suspension culture and the level of
involucrin protein was evaluated on Western blots. The data shown are
representative of three separate experiments.
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(Nanbu-Wakao et al., 2002; Floyd and Stephens, 2003). The
PPARg gene produces four different PPARg mRNAs by
alternative splicing and promoter usage. PPARg1 is expressed
ubiquitously (the PPARg expressed in keratinocytes is mainly
PPARg1), PPARg2 is restricted to adipose tissue, and PPARg3
is mainly confined to macrophages, adipose tissue, and the
colon (Fajas et al., 1998). The tissue expression of PPARg4
has not been investigated. Although a putative STAT5-
consensus motif in the human PPARg2 and PPARg3
promoters has been explored (Nanbu-Wakao et al., 2002;
Meirhaeghe et al., 2003), the presence of the STAT5 motif in
the PPARg1 promoter has not been reported (Fajas et al.,
1997). Therefore, to elucidate how STAT5a induces PPARg
expression during keratinocyte differentiation and determine
whether the PPARg expressed in skin is a direct target of
STAT5a requires further study. Another interesting finding is
that blocking the PPARg signal decreased STAT5a expression
in suspension culture slightly (data not shown), implying that
the PPARg and STAT5a signals regulate each other (Olsen
and Haldosen, 2006). Although the STAT5a/PPARg pathway
plays a role in involucrin expression, neither STAT5-deficent
mice (Coffer et al., 2000; Ikeda et al., 2005) nor PPARg-
deficient mice (Mao-Qiang et al., 2004) show any particular
skin defect. This feature can be explained by the fact that
blocking the activation of STAT5a or inhibiting the PPARg
signal only partially decreases the inducible expression
of involucrin.
Considering all of the available evidence, we suggest that
the activation of STAT5a by a challenge to keratinocyte
differentiation, such as suspension culture, contributes to
involucrin induction by regulating the PPARg signal. STAT5a
thus appears to be an initial transcription factor involved in
involucrin expression and keratinocyte differentiation and
this study provides early evidence that a STAT5a/PPARg
pathway plays a role in involucrin expression in normal
human keratinocytes.
MATERIALS AND METHODS
Keratinocyte culture
Primary normal human keratinocytes were isolated from surgically
discarded neonatal skin samples. This study was conducted
according to the Declaration of Helsinki Principles and all of the
procedures that involved human subjects received prior approval
from the Ethics Committee of Ehime University School of Medicine,
Japan. All subjects provided written informed consent.
Normal human keratinocytes were cultured in MCDB153
medium supplemented with insulin (1 mg/ml), hydrocortisone
(0.5 mg/ml), ethanolamine (0.1 mM), phosphoethanolamine
(0.1 mM), bovine hypothalamic extract (50mg/ml), and Ca2þ
(0.1 mM), as described elsewhere (Shirakata et al., 2004). Polyhy-
droxyethylmethacrylate-coated plates were made by coating with a
10-mg/ml solution of polyhydroxyethylmethacrylate (Sigma Chemi-
cal, St Louis, MO), and suspension cultures were performed as
described previously (Sayama et al., 2002).
Ax construction and Infection
The cosmid cassette pAxCAw and parent virus Ad5-dlX have been
described previously (Miyake et al., 1996). The full-length coding
region of dn-STAT5a cDNA, a dn mutant with phenylalanine
substituted for tyrosine at a phosphorylation site (Ariyoshi et al.,
2000; Nanbu-Wakao et al., 2002), was subcloned into pAxCAw. The
pcDNA3 expression vector expressing flag-tagged L468A/E471A
PPARg (dn-PPARg) was a gift from Professor Chatterjee (University of
Cambridge, Cambridge, UK). This double-mutant form of PPARg
exhibits impaired transcriptional activity and coactivator recruit-
ment, silences basal transcription by recruitment of corepressors,
and is a potent dn inhibitor of wild-type PPARg activity (Gurnell
et al., 2000). The full-length dn-PPARg cDNA was also cloned into
pAxCAw. Adenovirus containing the CA promoter and target gene
was generated by the Cosmid–terminal protein complex method
(Miyake et al., 1996). Recombinant viruses were generated through
homologous recombination in 293 cells; purified virus stocks were
prepared by the CsCl gradient method, and the virus titer was
checked with a plaque formation assay (Miyake et al., 1996).
Cultured normal human keratinocytes were infected with Ax; Ax1W
was used as the control vector to exclude the effect of Ax itself, as
described previously (Dai et al., 2004).
Real-time RT-PCR
Total RNA samples from cultured cells were isolated using Isogen
(Nippon Gene, Tokyo, Japan). Real-time reverse transcriptase-PCR
(RT–PCR) was performed and analyzed in an ABI PRISM 7700
sequence detector (PE Applied Biosystems, Branchburg, NJ). The
primers and probes for glyceraldehyde-3-phosphate dehydrogenase,
STAT5a, STAT5b, involucrin, and PPARs used for real-time PCR
were obtained from Applied Biosystems (Norwalk, CT). The RNA
analysis was carried out using a TaqMan RT-PCR Master Mix
reagents kit (Applied Biosystems). The cDNA synthesis and PCR
were performed as described previously (Dai et al., 2004), according
to the manufacturers’ protocols. The quantification of gene expres-
sion was performed using the comparative CT method as described
previously (Dai et al., 2004). The target gene expression in the test
samples was normalized to the corresponding glyceraldehyde-3-
phosphate dehydrogenase gene expression and was reported as the
fold difference relative to glyceraldehyde-3-phosphate dehydrogenase.
Western blotting
Keratinocytes were harvested at the indicated times after suspension
culture and whole-cell lysates and the nuclear fraction were
extracted as described previously (Yahata et al., 2003). Analyses
were performed using a Vistra ECF kit (Amersham Biosciences,
Arlington Heights, IL) according to the manufacturer’s instructions.
Twenty micrograms of protein was separated by 10% SDS–PAGE and
transferred to nitrocellulose membranes. The membranes were
blocked with 5% non-fat dry milk in Tris–HCl (pH 7.4), 0.15 M
NaCl, and 0.05% Tween-20, followed by overnight incubation with
mouse antibody against STAT5a or STAT5b (ZYMED Laboratories,
San Francisco, CA), rabbit anti-phospho-STAT5 (Cell Signaling
Technology, Beverly, MA), rabbit anti-involucrin (Biomedical
Technologies, Stoughton, MA), mouse anti-PPARg, goat anti-b-actin
(Santa Cruz Biotechnology, Santa Cruz, CA), or rabbit anti-PPARa or
b/d (Abcam, Cambridge, UK). After washing, the membrane was
incubated with a 1:2500 dilution of fluorescein-labeled IgG for
1 hour. The signal was amplified with an anti-fluorescein antibody
conjugated with alkaline phosphatase, followed by the fluorescent
substrate AttoPhos (Amersham Biosciences). The membrane was
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then scanned using a FluoroImager (Molecular Dynamics, Sunny-
vale, CA).
Preparation of nuclear extracts and EMSA
Nuclear proteins were isolated as described previously (Dignam
et al., 1983). Briefly, cells were scraped into a lysis buffer (50 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.8), 10 mM
KCl, 0.1 mM EDTA, pH 8.0, 1 mM dithiothreitol) containing a
protease-inhibitor cocktail and 0.5% NP-40. Nuclei were collected
by centrifugation and resuspended in 100 ml of 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid buffer without NP-40 and containing
420 mM KCl and 5 mM MgCl2. After a 30-minute incubation on ice,
nuclear debris was removed by centrifugation at 20,000 g for
15 minutes at 41C. Supernatants were collected and stored at 801C
until use.
EMSA was performed using a Light Shifts Chemiluminescent
EMSA kit (Pierce, Rockford, IL) according to the manufacturer’s
instructions. Specific PPARg, a, and b/d oligonucleotide probe sets
(biotin-labeled and unlabeled probes; Panomics, Redwood City, CA)
were used as described (Juge-Aubry et al., 1997). In brief, binding
reactions (20ml) containing 1 binding buffer, 50 ng/ml poly(dIdC),
biotin-labeled PPARg probe, and nuclear protein (5 mg) were
prepared and incubated at room temperature for 20 minutes. In
competition experiments, unlabeled probes were added at 100-fold
molar excess. For supershift assays, nuclear extracts were preincu-
bated with goat polyclonal anti-PPARg (Santa Cruz Biotechnology),
rabbit polyclonal anti-PPARa or b/d (Abcam), or with species-
matched control IgG for 1 hour at 41C, followed by the addition of a
biotin-labeled PPARg probe.
Protein–DNA complexes were separated by electrophoresis in
5% native polyacrylamide gels and transferred to Biodynes B nylon
membranes (Pierce). The labeled DNA was cross-linked to the
membrane by exposure to 302-nm UV radiation on a UV
transilluminator for 1 minute. The biotin-labeled molecules in the
membrane were detected using a chemiluminescent nucleic acid
detection module (Pierce). The membrane was briefly soaked in a
blocking solution, incubated in conjugate/blocking solution for
15 minutes, washed four times in wash buffer and once in substrate
equilibration buffer, incubated in substrate working solution for
5 minutes, and exposed to X-ray film.
Luciferase assay
A reporter plasmid containing the involucrin promoter and firefly
luciferase (pINV-Luc) was constructed, as described previously
(Sayama et al., 2001). To normalize the transfection efficiency, a
plasmid containing Renilla luciferase driven by the herpes simplex
virus thymidine kinase promoter (pRL-TK; Promega, Madison, WI)
was included in the assay. The reporter plasmids were introduced
into the keratinocytes using FuGENE6 (Roche Molecular Biochem-
icals, Indianapolis, IN) according to the manufacturer’s instructions.
After 24 hours, the cells were infected with the indicated adenovirus
or treated with HX531 and subjected to suspension culture for
24 hours. Then, the same number of cells was harvested with 250 ml
of lysis buffer (Promega) and the luciferase activity was measured
using the Dual-Luciferase reporter assay system (Promega) with a
luminometer (Luminescencer JNR AB-2100; Atto, Osaka, Japan).
The relative luciferase activity was calculated by normalizing to the
Renilla luciferase activity.
Chemical
HX531 was synthesized as described elsewhere (Yamauchi et al.,
2001) and dissolved in DMSO.
Statistical analysis
At least three independent experiments were performed with similar
results. One representative experiment is shown in each figure.
Statistical significance was determined using Student’s paired t-test.
Differences were considered statistically significant at Po0.05 (*).
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Teruko Tsuda and Eriko Tan for their excellent technical assistance.
This work was supported by grants from the Ministries of Health, Labor, and
Welfare and Education, Culture, Sports, Science, and Technology of Japan.
REFERENCES
Ariyoshi K, Nosaka T, Yamada K, Onishi M, Oka Y, Miyajima A et al. (2000)
Constitutive activation of STAT5 by a point mutation in the SH2 domain.
J Biol Chem 275:24407–13
Coffer PJ, Koenderman L, de Groot RP (2000) The role of STATs in myeloid
differentiation and leukemia. Oncogene 19:2511–22
Dai X, Yamasaki K, Shirakata Y, Sayama K, Hashimoto K (2004) All-trans-
retinoic acid induces interleukin-8 via the nuclear factor-kappaB and
p38 mitogen-activated protein kinase pathways in normal human
keratinocytes. J Invest Dermatol 123:1078–85
Demerjian M, Man MQ, Choi EH, Brown BE, Crumrine D, Chang S et al.
(2006) Topical treatment with thiazolidinediones, activators of peroxi-
some proliferator-activated receptor-gamma, normalizes epidermal
homeostasis in a murine hyperproliferative disease model. Exp Dermatol
15:154–60
Dignam JD, Martin PL, Shastry BS, Roeder RG (1983) Eukaryotic gene
transcription with purified components. Methods Enzymol 101:582–98
Eckert RL, Crish JF, Efimova T, Dashti SR, Deucher A, Bone F et al. (2004)
Regulation of involucrin gene expression. J Invest Dermatol 123:13–22
Ellis CN, Varani J, Fisher GJ, Zeigler ME, Pershadsingh HA, Benson SC et al.
(2000) Troglitazone improves psoriasis and normalizes models of
proliferative skin disease: ligands for peroxisome proliferator-activated
receptor-gamma inhibit keratinocyte proliferation. Arch Dermatol
136:609–16
Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R et al.
(1997) The organization, promoter analysis, and expression of the human
PPARg gene. J Biol Chem 272:18779–89
Fajas L, Fruchart JC, Auwerx J (1998) PPARgamma3 mRNA: a distinct PPARg
mRNA subtype transcribed from an independent promoter. FEBS Lett
438:55–60
Floyd ZE, Stephens JM (2003) STAT5A promotes adipogenesis in nonpre-
cursor cells and associates with the glucocorticoid receptor during
adipocyte differentiation. Diabetes 52:308–14
Grimley PM, Dong F, Rui H (1999) Stat5a and Stat5b: fraternal twins of signal
transduction and transcriptional activation. Cytokine Growth Factor Rev
10:131–57
Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN,
Provenzano C et al. (2000) A dominant-negative peroxisome prolif-
erator-activated receptor gamma (PPARgamma) mutant is a constitutive
repressor and inhibits PPARgamma-mediated adipogenesis. J Biol Chem
275:5754–9
Horvath CM (2000) STAT proteins and transcriptional responses to
extracellular signals. Trends Biochem Sci 25:496–502
Ikeda K, Nakajima H, Suzuki K, Watanabe N, Kagami S, Iwamoto I (2005)
Stat5a is essential for the proliferation and survival of murine mast cells.
Int Arch Allergy Immunol 137(Suppl 1):45–50
1734 Journal of Investigative Dermatology (2007), Volume 127
X Dai et al.
STAT5a Regulates Involucrin Expression
Juge-Aubry C, Pernin A, Favez T, Burger AG, Wahli W, Meier CA et al.
(1997) DNA binding properties of peroxisome proliferator-activated
receptor subtypes on various natural peroxisome proliferator response
elements. Importance of the 5’-flanking region. J Biol Chem 272:
25252–9
Kuenzli S, Saurat JH (2003) Peroxisome proliferator-activated receptors in
cutaneous biology. Br J Dermatol 149:229–36
Levy DE, Gilliland DG (2000) Divergent roles of STAT1 and STAT5 in
malignancy as revealed by gene disruptions in mice. Oncogene
19:2505–10
Mao-Qiang M, Fowler AJ, Schmuth M, Lau P, Chang S, Brown BE et al. (2004)
Peroxisome-proliferator-activated receptor (PPAR)-gamma activa-
tion stimulates keratinocyte differentiation. J Invest Dermatol 123:
305–12
Matsuura H, Adachi H, Smart RC, Xu X, Arata J, Jetten AM (1999) Correlation
between expression of peroxisome proliferator-activated receptor beta
and squamous differentiation in epidermal and tracheobronchial
epithelial cells. Mol Cell Endocrinol 147:85–92
Meirhaeghe A, Fajas L, Gouilleux F, Cottel D, Helbecque N, Auwerx J et al.
(2003) A functional polymorphism in a STAT5B site of the human PPAR
gamma 3 gene promoter affects height and lipid metabolism in a French
population. Arterioscler Thromb Vasc Biol 23:289–94
Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K et al.
(1996) Efficient generation of recombinant adenoviruses using adeno-
virus DNA-terminal protein complex and a cosmid bearing the full-
length virus genome. Proc Natl Acad Sci USA 93:1320–4
Nanbu-Wakao R, Morikawa Y, Matsumura I, Masuho Y, Muramatsu MA,
Senba E et al. (2002) Stimulation of 3T3-L1 adipogenesis by signal
transducer and activator of transcription 5. Mol Endocrinol 16:1565–76
Nishio H, Matsui K, Tsuji H, Tamura A, Suzuki K (2001) Immunolocalisation
of the janus kinases (JAK) – signal transducers and activators of
transcription (STAT) pathway in human epidermis. J Anat 198:581–9
Olsen H, Haldosen LA (2006) Peroxisome proliferator-activated receptor
gamma regulates expression of signal transducer and activator of
transcription 5A. Exp Cell Res 312:1371–80
Poumay Y, Jolivet G, Pittelkow MR, Herphelin F, De Potter IY, Mitev V et al.
(1999) Human epidermal keratinocytes upregulate expression of the
prolactin receptor after the onset of terminal differentiation, but do not
respond to prolactin. Arch Biochem Biophys 364:247–53
Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S (1998)
Differential expression of peroxisome proliferator-activated receptor
subtypes during the differentiation of human keratinocytes. J Invest
Dermatol 111:1116–21
Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional
regulation of adipogenesis. Genes Dev 14:1293–307
Sayama K, Hanakawa Y, Shirakata Y, Yamasaki K, Sawada Y, Sun L et al.
(2001) Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular
inducer of keratinocyte differentiation. J Biol Chem 276:999–1004
Sayama K, Yamasaki K, Hanakawa Y, Shirakata Y, Tokumaru S, Ijuin T et al.
(2002) Phosphatidylinositol 3-kinase is a key regulator of early phase
differentiation in keratinocytes. J Biol Chem 277:40390–6
Segaert S, Garmyn M, Degreef H, Bouillon R (1998) Anchorage-dependent
expression of the vitamin D receptor in normal human keratinocytes.
J Invest Dermatol 111:551–8
Shirakata Y, Ueno H, Hanakawa Y, Kameda K, Yamasaki K, Tokumaru S et al.
(2004) TGF-beta is not involved in early phase growth inhibition of
keratinocytes by 1alpha,25(OH)2vitamin D3. J Dermatol Sci 36:41–50
Stephens JM, Morrison RF, Wu Z, Farmer SR (1999) PPARgamma ligand-
dependent induction of STAT1, STAT5A, and STAT5B during adipogen-
esis. Biochem Biophys Res Commun 262:216–22
Stewart WC, Baugh JE Jr, Floyd ZE, Stephens JM (2004) STAT 5 activators can
replace the requirement of FBS in the adipogenesis of 3T3-L1 cells.
Biochem Biophys Res Commun 324:355–9
Varley CL, Stahlschmidt J, Smith B, Stower M, Southgate J (2004) Activation of
peroxisome proliferator-activated receptor-gamma reverses squamous
metaplasia and induces transitional differentiation in normal human
urothelial cells. Am J Pathol 164:1789–98
Wakita H, Takigawa M (1999) Activation of epidermal growth factor receptor
promotes late terminal differentiation of cell-matrix interaction-disrupted
keratinocytes. J Biol Chem 274:37285–91
Watt FM, Jordan PW, O’Neill CH (1988) Cell shape controls terminal
differentiation of human epidermal keratinocytes. Proc Natl Acad Sci
USA 85:5576–80
Westergaard M, Henningsen J, Svendsen ML, Johansen C, Jensen UB,
Schroder HD et al. (2001) Modulation of keratinocyte gene expression
and differentiation by PPAR-selective ligands and tetradecylthioacetic
acid. J Invest Dermatol 116:702–12
Yahata Y, Shirakata Y, Tokumaru S, Yamasaki K, Sayama K, Hanakawa Y
et al. (2003) Nuclear translocation of phosphorylated STAT3 is essential
for vascular endothelial growth factor-induced human dermal micro-
vascular endothelial cell migration and tube formation. J Biol Chem
278:40026–31
Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K, Komeda K et al.
(2001) Inhibition of RXR and PPARgamma ameliorates diet-induced
obesity and type 2 diabetes. J Clin Invest 108:1001–13
www.jidonline.org 1735
X Dai et al.
STAT5a Regulates Involucrin Expression
